ライフサイエンスコーパス: euthanasia

1 f age, spinal cords were processed following euthanasia.

2 e at 48 h, negative at 72 h, and positive at euthanasia.

3 death or severe clinical signs necessitating euthanasia.

4 dard chow diet (4.5% fat) from weaning until euthanasia.

5 35 SIVmac239-infected animals at the time of euthanasia.

6 th, pneumonia, and pyelonephritis, requiring euthanasia.

7 ental inoculation of mice presently requires euthanasia.

8 not distinguish between assisted suicide and euthanasia.

9 ent with unremitting pain and 6.5% supported euthanasia.

10 elevated blood cholesterol and monocytes at euthanasia.

11 onary injury and continued for 28 days until euthanasia.

12 are becoming increasingly opposed to PAS and euthanasia.

13 ed before drug and at 3 weeks of drug before euthanasia.

14 from patients for assistance with suicide or euthanasia.

15 de, and 4% received one or more requests for euthanasia.

16 oped acute respiratory distress and required euthanasia.

17 ns related to physician-assisted suicide and euthanasia.

18 (HRP) was administered intravenously before euthanasia.

19 nd/or coagulopathy that prompted unscheduled euthanasia.

20 ull veterinary workup and diagnosis prior to euthanasia.

21 admill and limb strength testing followed by euthanasia.

22 reasing age were additional risk factors for euthanasia.

23 gns and acute respiratory distress requiring euthanasia.

24 s of the brain with (13)C, followed by rapid euthanasia.

25 time with live animals without the need for euthanasia.

26 t to an unrelated cardiomyopathy that led to euthanasia.

27 started at 5 days of age and continued until euthanasia.

28 photographs were taken at day 7 before doing euthanasia.

29 y tissue samples were obtained following the euthanasia.

30 14th day post-ovariectomy/sham surgery until euthanasia.

31 s of cerebellar ataxia and the owner elected euthanasia.

32 or distress to which mice are exposed during euthanasia.

33 ted at baseline and every 6 to 8 weeks until euthanasia.

34 togenes (Lm) for 36 hours or 72 hours before euthanasia.

35 e, first by open surgical biopsy and then by euthanasia.

36 Of 58 patients who requested euthanasia, 14 (24%) received parenteral medication and

37 est and control sites at baseline and before euthanasia (16 weeks).

38 After euthanasia, 16 orbits were examined by high-resolution m

39 ng and thickness were assessed and following euthanasia 2-4 wk after serum transfer, paws were prepar

40 day 420 after tick exposure and again before euthanasia, 2 dogs of each group were treated with predn

41 hronic myocardial infarction (3 months), and euthanasia (6.6 months), we measured left ventricular (L

42 ose without (53.8% v 31.7%; P < .001) as did euthanasia (6.8% v 0.9%; P < .001).

43 lls developed disseminated disease requiring euthanasia 73-96 days after injection of cells.

44 istorical records of public attitudes toward euthanasia across numerous countries uncovered anticipat

45 When compared to the gradually rising CO(2) euthanasia, addition of a high concentration of N(2)O to

46 Assisted dying and euthanasia (ADE) for patients with psychiatric disorders

47 on at postinfection (PI) day 28, followed by euthanasia after 1 hour.

48 on dioxide (CO(2)) is the most commonly used euthanasia agent for rodents despite potentially causing

49 At euthanasia, all animals had low to undetectable viral lo

50 At euthanasia, all CD8, but no CD4, Gag epitopes detected d

51 , 3.7% of surveyed oncologists had performed euthanasia and 10.8% had performed physician-assisted su

52 Mice underwent euthanasia and 60 minutes warm ischemia, and lungs were

53 nical signs of the cat prompted humanitarian euthanasia and a detailed postmortem investigation to as

54 Mice underwent euthanasia and aortic root dissection.

55 Euthanasia and assisted suicide has received considerabl

56 y jurisdictions have moved toward legalizing euthanasia and assisted suicide, alongside a near-univer

57 As public debate continues about euthanasia and assisted suicide, some critical care nurs

58 out their attitudes and practices related to euthanasia and assisted suicide.

59 is review focuses on some aspects of PAS and euthanasia and discusses deep terminal sedation (DTS), w

60 es inoculated group were culture positive at euthanasia and displayed bone changes at the interface o

61 ving sterile screws were culture-negative at euthanasia and displayed progressive bony encapsulation

62 ed 6 hours after the final procedure, before euthanasia and formalin perfusion of the NHP; we then pe

63 us exposure to gradually rising CO(2) during euthanasia and hence may reduce the duration of any stre

64 ted on postlaser days 30 and 35, followed by euthanasia and histologic analysis of tissues.

65 iter), and use of less traumatic methods for euthanasia and organ harvest.

66 antation of livers arising through DCD after euthanasia and organ procurement with super-rapid cold p

67 aluated the stability of attitudes regarding euthanasia and PAS among three cohorts.

68 udies of seriously ill patients' interest in euthanasia and PAS, there are no data on the attitudes a

69 ts (72.6% response rate) were interviewed on euthanasia and PAS.

70 Although euthanasia and physician-assisted suicide (PAS) are cont

71 Euthanasia and physician-assisted suicide (PAS) are high

72 are few data examining the details of actual euthanasia and physician-assisted suicide (PAS) cases in

73 ds of oncology patients and the public found euthanasia and physician-assisted suicide acceptable for

74 Euthanasia and physician-assisted suicide are important

75 Euthanasia and physician-assisted suicide are increasing

76 Requests for euthanasia and physician-assisted suicide are likely to

77 Euthanasia and physician-assisted suicide are pressing p

78 nses to survey questions on attitudes toward euthanasia and physician-assisted suicide for a terminal

79 an increasing and strong public support for euthanasia and physician-assisted suicide has been repor

80 Public support for euthanasia and physician-assisted suicide in the United

81 Oncology patients and the public found euthanasia and physician-assisted suicide least acceptab

82 The practices of euthanasia and physician-assisted suicide remain controv

83 The increasing legalization of euthanasia and physician-assisted suicide worldwide make

84 itting pain, requests for and performance of euthanasia and physician-assisted suicide, and sociodemo

85 eir attitudes and experiences in relation to euthanasia and physician-assisted suicide.

86 rus lacking the leader gene (A12-LLV2), with euthanasia and tissue collection at 24 and 72 h postexpo

87 nd coronary angiography 7 weeks later before euthanasia and tissue harvest.

88 24 and 48 hours after infection, followed by euthanasia and vitreous harvest to quantitate bacterial

89 Euthanasia and withdrawal of life-prolonging treatment w

90 nship between physician-assisted suicide and euthanasia and withholding or withdrawing life support,

91 assisted suicide for themselves, 85.8% found euthanasia and/or assisted suicide acceptable for their

92 pate in either assisted suicide or voluntary euthanasia, and 13 percent would participate only in ass

93 nt, 23% for assisted suicide, 32% for active euthanasia, and 41% for double effect.

94 requests for physician-assisted suicide and euthanasia, and about 7 percent of those who responded t

95 regoing life-sustaining treatment and active euthanasia, and health professionals' difficulty recogni

96 logical examination because of laceration at euthanasia, and the other PFO was clinically closed, wit

97 available) reported that they had engaged in euthanasia; and an additional 36 (4 percent) reported th

98 In addition, at euthanasia, antigen-specific cells producing gamma inter

99 Physician-assisted suicide and euthanasia are complex moral issues.

100 t request for physician-assisted suicide and euthanasia are not rare.

101 Physician-assisted suicide and euthanasia are topics that engender a strong negative re

102 Caution is warranted regarding PAS and euthanasia, as vulnerable patients may still be at risk.

103 V swarm, while two of four controls required euthanasia at 10 and 11 weeks.

104 eloped a similar disease syndrome, requiring euthanasia at 11 weeks PI of the kittens.

105 controlled their viremia until their time of euthanasia at 200 weeks postchallenge.

106 ved without complication until predetermined euthanasia at 28 days.

107 rTAP and vehicle control was observed after euthanasia at 28 days.

108 or Stx2 (n = 5) in plasma samples from T0 to euthanasia at 49.5 to 128 hours post-challenge.

109 ntially slower increase in proteinuria until euthanasia at 50 wk.

110 nd equal caloric intake was maintained until euthanasia at 7 months.

111 AP or vehicle on day 0 and at 72 hours, with euthanasia at 78 hours after balloon denudation.

112 7 weeks of age and texturized starter until euthanasia at 9 weeks of age, when the RE tissues were c

113 n day 12 of pregnancy and continuing through euthanasia at day 14 postpartum.

114 After euthanasia at day 60, the esophagus was evaluated visual

115 oral gavage 4 weeks prior to surgeries until euthanasia at day 7 or 14 post-surgery.

116 was collected for haematology counts, until euthanasia at day 7 post-challenge.

117 BrdU was infused for 7 days before euthanasia at days 10, 17, and 38 or during injury and a

118 or both scientific study, humane killing and euthanasia at end of life.

119 ted in Tempus RNA tubes immediately prior to euthanasia, at day 7 post-challenge.

120 avium, and Campylobacter coli that required euthanasia between weeks 100 and 199 p.i.

121 ion and developed clinical disease requiring euthanasia between weeks 12 and 23 postinfection.

122 loss of memory CD4(+) T cells that required euthanasia between weeks 19 and 23 postinfection.

123 After euthanasia, biochemical parameters were evaluated in ser

124 In euthanasia, blood, maxillae, and gingival samples were r

125 Cats that were selected for euthanasia by the shelter staff and additionally had URI

126 e appropriate, treated for depression before euthanasia can be discussed seriously.

127 .03]-rate = 1.02 [95%CI: 0.99; 1.04]), while euthanasia cases for dementia increased faster than othe

128 s euthanasia for terminal illnesses, whereas euthanasia cases involving cognitive conditions increase

129 icians from the End-of-Life Clinic, a mobile euthanasia clinic.

130 ollowed trends similar to the other types of euthanasia (count = 1.00 [95%CI: 0.98; 1.03]-rate = 1.02

131 ementia increased faster than other types of euthanasia (count = 1.03 [95%CI: 1.00; 1.06]-rate = 1.04

132 ates used, routes and doses of exposure, and euthanasia criteria, all of which may contribute to vari

133 In contradistinction to euthanasia, deactivation of an LVAD does not introduce n

134 Quantitative cultures at euthanasia demonstrated no growth in either SIS group co

135 Repeat catheterization before euthanasia demonstrated statistically significant differ

136 diet, resulting in 50% longer survival until euthanasia, determined by tumor size, of the prenatally

137 ollected and reported longitudinal data, and euthanasia did not improve virus detection.

138 eatment or (177)Lu-DOTA-Bn only), leading to euthanasia due to excessive tumor burden, whereas 10 of

139 n animal that is independently scheduled for euthanasia due to spontaneous disease-becomes available.

140 jected with BrdU (100 mg/kg BID) followed by euthanasia either 24 h or 2 weeks after the last injecti

141 Commission for the Control and Evaluation of Euthanasia (FCCEE) from September 1, 2002, to December 3

142 Following euthanasia, femoral arterial segments were isolated and

143 Following euthanasia, femur biomechanics were assessed by 3-point

144 2002 and 2023, there are distinct trends for euthanasia for non-terminal illnesses.

145 Euthanasia for psychiatric disorders followed similar tr

146 Although slightly increasing, euthanasia for psychiatric disorders followed trends sim

147 infused stem cells generally require animal euthanasia for single-time-point determinations of engra

148 hiatric disorders followed similar trends as euthanasia for terminal illnesses, whereas euthanasia ca

149 h documented immunodeficiency at the time of euthanasia, for their capacity to establish durable infe

150 es related to physician-assisted suicide and euthanasia from the perspective of healthcare profession

151 ERBs from the serial euthanasia group exhibit high KASV loads indicative of v

152 Immediately before euthanasia, half of CW, EW and NW animals were socially

153 hics of physician-assisted suicide (PAS) and euthanasia have been examined in many cross-sectional st

154 Physician-assisted suicide (PAS) and euthanasia have been increasingly discussed in end-of-li

155 ly discussed in end-of-life care, as PAS and euthanasia have now been legalized in three European cou

156 erely tumored stranded turtles that required euthanasia (high FP, 100%, Main Hawaiian Islands).

157 confirmed through infrared imaging and post-euthanasia histology studies via energy-dispersive spect

158 dings (obtained 6 hours after IRE and before euthanasia), histopathologic characteristics, and simula

159 ntly more likely to have seriously discussed euthanasia, hoarded drugs, or read Final Exit.

160 ate regarding physician-assisted suicide and euthanasia holds implications for the practice of critic

161 nction and resulted in death or the need for euthanasia in all seven animals.

162 ore likely to change toward opposing PAS and euthanasia in all vignettes (P <.05).

163 about the current approach to assisted dying/euthanasia in Canada.

164 y telephone, regarding acceptance of PAS and euthanasia in four different clinical vignettes.

165 by decreased mortality and prolonged time to euthanasia in macaques.

166 to evaluating physician-assisted suicide and euthanasia in medical practice: 1) the benefit or harm o

167 on related to physician-assisted suicide and euthanasia in the critical care setting.

168 ny studies of physician-assisted suicide and euthanasia in the United States, national data are lacki

169 garding the ethical acceptability of PAS and euthanasia in their follow-up interview.

170 to uniform severe weakness at 24 h requiring euthanasia in untreated animals, anti-C5 mAb-pretreated

171 If euthanasia is delayed, the clinical signs will ascend, c

172 brain death at a hospital in Belgium, where euthanasia is legalized.

173 Physician-assisted suicide, excluding euthanasia, is legal in 5 US states (Oregon, Washington,

174 After euthanasia, mLPP was repeated.

175 The method of euthanasia most commonly described was the administratio

176 At euthanasia, MR progressed to moderate to severe in contr

177 Euthanasia occurred 30 days after the initiation of the

178 Euthanasia occurred at 7 and 14 days after the initiatio

179 Euthanasia occurred at day 44.

180 Euthanasia occurred in the 16th week.

181 progressed more rapidly, with a mean time to euthanasia of 3-6 months.

182 es), or mild (1 macaque) with a mean time to euthanasia of 7 months.

183 ly growing and invasive tumors necessitating euthanasia of all mice by 15 days post injection.

184 CDV FAT to these samples avoids unnecessary euthanasia of dogs with suspected CDV.

185 After euthanasia of female Wistar rats, followed by orbital ex

186 Additionally, euthanasia of healthy animals in overpopulated shelters

187 This assay does not require euthanasia of rodents, which is especially important for

188 ty had limited impact on the attitudes about euthanasia of terminally ill cancer patients.

189 After euthanasia of the animals, lung tissue was sampled for p

190 Following euthanasia of the pigs on d60, placental and fetal morph

191 r tissue samples were obtained following the euthanasia of the rats in all groups.

192 e, and lung samples were collected following euthanasia on day 251 p.i.

193 occlusion, after reperfusion, and preceding euthanasia on day 7.

194 induction and Met gavage on the 19th day and euthanasia on the 30th day.

195 s from patients or family members to perform euthanasia or assist in suicide; 129 (16 percent of thos

196 Euthanasia or assisted suicide (EAS) of psychiatric pati

197 agine a situation in which they might desire euthanasia or assisted suicide for themselves but found

198 agine a situation in which they might desire euthanasia or assisted suicide for themselves, 41.7% sti

199 agine a situation in which they might desire euthanasia or assisted suicide for themselves, 85.8% fou

200 When physicians desire euthanasia or assisted suicide for themselves, they are

201 agine a situation in which they might desire euthanasia or assisted suicide for themselves.

202 ients (surrogates), or physicians to perform euthanasia or assisted suicide, as well as their own pra

203 agine a situation in which they would desire euthanasia or assisted suicide.

204 the NA EEEV-infected animals at the time of euthanasia or death.

205 5.6%) had discussed asking the physician for euthanasia or PAS and 6 (2.5%) had hoarded drugs.

206 Most patients (69%) supported euthanasia or PAS for one or more situations.

207 e terminally ill patients who had considered euthanasia or PAS for themselves changed their minds, wh

208 terminally ill patients seriously considered euthanasia or PAS for themselves.

209 ut only 10.6% reported seriously considering euthanasia or PAS for themselves.

210 lly ill patients, a total of 60.2% supported euthanasia or PAS in a hypothetical situation, but only

211 ssociated with being more likely to consider euthanasia or PAS were depressive symptoms (OR, 1.25; 95

212 ssociated with being less likely to consider euthanasia or PAS were feeling appreciated (odds ratio [

213 patient initiate and repeat the request for euthanasia or PAS, (2) ensuring the patient was experien

214 tely, of the 256 decedents, 1 (0.4%) died by euthanasia or PAS, 1 unsuccessfully attempted suicide, a

215 ed comfort from having helped a patient with euthanasia or PAS, 9 (23.7%) regretted having performed

216 or PAS, 9 (23.7%) regretted having performed euthanasia or PAS, and 15 (39.5%) feared prosecution.

217 oth initiated and repeated their request for euthanasia or PAS, but 6 patients (15.8%) did not partic

218 ore likely to change their minds to consider euthanasia or PAS.

219 likely to change their minds about desiring euthanasia or PAS.

220 .8%) did not participate in the decision for euthanasia or PAS.

221 spice care does not obviate their desire for euthanasia or PAS.

222 olute requirements for physicians to perform euthanasia or PAS.

223 e adverse consequences from having performed euthanasia or PAS.

224 cologists described clearly defined cases of euthanasia or PAS.

225 ncologists (15.8%) reported participating in euthanasia or PAS; 53 oncologists (94.6% response rate)

226 staining treament on the one hand and active euthanasia or physician-assisted dying on the other.

227 tial care needs were more likely to consider euthanasia or physician-assisted suicide (P = 0.001).

228 ncology patients had seriously thought about euthanasia or physician-assisted suicide and nearly 12 p

229 that vulnerable patients have been receiving euthanasia or physician-assisted suicide at rates higher

230 Currently, euthanasia or physician-assisted suicide can be legally

231 ing pain--did a majority of oncologists find euthanasia or physician-assisted suicide ethically accep

232 n 0.3% to 4.6% of all deaths are reported as euthanasia or physician-assisted suicide in jurisdiction

233 y experiencing pain were more likely to find euthanasia or physician-assisted suicide unacceptable.

234 ysicians report having received requests for euthanasia or physician-assisted suicide, and 5% or less

235 , 0.71 to 0.87]) were less likely to support euthanasia or physician-assisted suicide.

236 is or her life; and patient consideration of euthanasia or physician-assisted suicide.

237 to 0.95]) were less likely to have performed euthanasia or physician-assisted suicide.

238 deaths in the Netherlands are the result of euthanasia or physician-assisted suicide.

239 rly one in seven oncologists had carried out euthanasia or physician-assisted suicide.

240 alf of oncologists had received requests for euthanasia or physician-assisted suicide.

241 (OR 3.40, 95% CI 2.88-4.01) and post-return euthanasia (OR 3.94, 95% CI 2.04-7.59).

242 vs 0.07; 95% CI, 0.22-0.46 vs 0.03-0.12) and euthanasia (OR, 0.22 vs 0.01; 95% CI, 0.11-0.41 vs 0-0.1

243 nt needed were more likely to have performed euthanasia (P = 0.001).

244 ve was to assess whether the attitudes about euthanasia/PAS of terminally ill cancer patients were de

245 Statements related to the legalization of euthanasia/PAS were scored using Likert scales.

246 PAS and euthanasia present potential risks for vulnerable popula

247 could be used as a welfare refinement of the euthanasia process in mice, by shortening the duration o

248 nuous local field potential (LFP) during the euthanasia process to show the dynamic changes of freque

249 aine study, two groups of rats underwent the euthanasia process: freely-moving and anesthetized.

250 terilization of Afro-Germans, and the German euthanasia program.

251 After euthanasia, pulmonary uptake of (18)F-FHBG was determine

252 In patients with cancer, euthanasia rates increased strongly and life-ending acts

253 isolated from four NPs at the time of their euthanasia remained R5 tropic.

254 All cases of euthanasia reported to the FCCEE during the selected per

255 made available online by the Dutch regional euthanasia review committees as of June 1, 2015.

256 The euthanasia review committees found that one case failed

257 hout independent psychiatric input), but the euthanasia review committees generally defer to the judg

258 w process of the patients' requests, and the euthanasia review committees' assessments of the physici

259 At euthanasia, serum cytokines and sialoadenitis severity w

260 Owners of both dogs elected for euthanasia shortly after the onset of signs.

261 non-human primate has traditionally required euthanasia, significantly limiting the ability to conduc

262 At euthanasia, single tissues of the antibiotic-treated dog

263 A timed euthanasia study showed delayed viral replication of RVF

264 associated with attitudes regarding PAS and euthanasia, such as Roman Catholic religion, were not pr

265 Upon euthanasia, T-cell responses were tested from a number o

266 sician-assisted suicide and voluntary active euthanasia than is ordinarily acknowledged.

267 ere toxicities leading to death or requiring euthanasia than S-PRT of the same dose.

268 After euthanasia, the cisterna chyli and the tumor are exposed

269 After euthanasia, the jaw segments were evaluated for bone thi

270 After euthanasia, the lung and spleen were removed for pro- an

271 One hour prior to euthanasia, the mice received an intraperitoneal injecti

272 ly physicians could perceive of a desire for euthanasia themselves and whether they would be willing

273 After euthanasia, there were no macroscopically visible lesion

274 control and 3 septic groups depending on the euthanasia time (24 h, 48 h, 72 h).

275 without airway obstruction until the planned euthanasia timepoint.

276 After euthanasia, tissue radioactivity was determined in a gam

277 At euthanasia, tissues were processed for semiquantitative

278 erwent endocardial/epicardial remapping, and euthanasia to enable histopathologic examination.

279 eoxyuridine was administered 24 hours before euthanasia to label proliferating cells.

280 e and immediately after NIMR creation and at euthanasia; vena contracta area, mitral annular dimensio

281 ; P =.001) and more stable responses for all euthanasia vignettes (P <.001) except for pain.

282 sician-assisted suicide and voluntary active euthanasia, voluntarily stopping eating and drinking and

283 fter transplantation of livers donated after euthanasia vs after circulatory death or brain death at

284 During the period from 1998 to 2007, when euthanasia was legalized and palliative care intensified

285 In Belgium, where euthanasia was legalized in mid-2002, cases rose from 23

286 ed by viral burdens, CD4 counts, and time to euthanasia was observed.

287 re injected over the course of 13 weeks, and euthanasia was performed 14 weeks after surgery in both

288 Euthanasia was performed if the serum creatinine concent

289 increase in the septic groups as the time to euthanasia was prolonged (p < 0.05).

290 MLPP after euthanasia was significantly decreased compared to mLPP

291 Agreement with euthanasia was significantly related to male sex, lack o

292 of premature death (death prior to scheduled euthanasia) was assessed.

293 Mandibular block sections obtained after euthanasia were decalcified and embedded in paraffin.

294 During the selected period, 33 647 cases of euthanasia were reported (50.23% male; 84.74% 60 years o

295 y samples or samples obtained at the time of euthanasia were used in this analysis.

296 doption (donation campaigns), treatment, and euthanasia when necessary (particularly due to advanced

297 determining success rates was the time from euthanasia, which was taken as a proxy for the stiffness

298 nd vaginal biopsy samples, and in tissues at euthanasia with an SIV(mac) Gag-specific tetramer.

299 those as a result of symptom alleviation and euthanasia, with a decrease in life-ending acts without

300 herlands, a small number of patients undergo euthanasia without an explicit request.